Kuwait’s Gulf Investment Corporation has acquired a 35 percent minority stake in Saudi Arabia’s Sudair Pharmaceuticals Co., the investment company said on Wednesday.

 

Sudair Pharmaceuticals is developing the Sudair Specialized Pharmaceuticals Complex, in which advanced cancer treatment drugs are being developed for the first time in the Middle East.

 

The 77,000 square meter project comprises a plant for chemotherapy drugs, as well as administrative offices, a research center and a training academy. 

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request